BOT.AX
Price:
$0.455
Market Cap:
$827.02M
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that ...[Read more]
Industry
Biotechnology
IPO Date
1988-01-31
Stock Exchange
ASX
Ticker
BOT.AX
According to Botanix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is -45.50. This represents a change of 361.15% compared to the average of -9.87 of the last 4 quarters.
The mean historical PE Ratio of Botanix Pharmaceuticals Limited over the last ten years is -13.31. The current -45.50 PE Ratio has changed 34.08% with respect to the historical average. Over the past ten years (40 quarters), BOT.AX's PE Ratio was at its highest in in the December 2020 quarter at 45.79. The PE Ratio was at its lowest in in the January 2011 quarter at -3504.12.
Average
-13.31
Median
-10.81
Minimum
-34.10
Maximum
-2.18
Discovering the peaks and valleys of Botanix Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 969.57%
Maximum Annual PE Ratio = -2.18
Minimum Annual Increase = -81.96%
Minimum Annual PE Ratio = -34.10
Year | PE Ratio | Change |
---|---|---|
2024 | -34.10 | 108.10% |
2023 | -16.39 | 289.12% |
2022 | -4.21 | -81.96% |
2021 | -23.35 | 969.57% |
2020 | -2.18 | -73.57% |
2019 | -8.26 | 69.41% |
2018 | -4.88 | 24.65% |
2017 | -3.91 | -70.72% |
2016 | -13.36 | -40.61% |
2015 | -22.50 | -44.26% |
The current PE Ratio of Botanix Pharmaceuticals Limited (BOT.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-18.23
5-year avg
-16.05
10-year avg
-13.31
Botanix Pharmaceuticals Limited’s PE Ratio is less than MGC Pharmaceuticals Limited (-0.57), less than Zelira Therapeutics Limited (-0.20), less than Creso Pharma Limited (-0.40), less than Cann Group Limited (-0.33), less than Althea Group Holdings Limited (-0.43),
Company | PE Ratio | Market cap |
---|---|---|
-0.57 | $18.42M | |
-0.20 | $7.15M | |
-0.40 | $23.11M | |
-0.33 | $20.90M | |
-0.43 | $13.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Botanix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Botanix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Botanix Pharmaceuticals Limited's PE Ratio?
How is the PE Ratio calculated for Botanix Pharmaceuticals Limited (BOT.AX)?
What is the highest PE Ratio for Botanix Pharmaceuticals Limited (BOT.AX)?
What is the 3-year average PE Ratio for Botanix Pharmaceuticals Limited (BOT.AX)?
What is the 5-year average PE Ratio for Botanix Pharmaceuticals Limited (BOT.AX)?
How does the current PE Ratio for Botanix Pharmaceuticals Limited (BOT.AX) compare to its historical average?